Aastrom Biosciences, Inc. (ASTM) to Present at the 2013 Stem Cell Meeting on the Mesa Conference
10/10/2013 9:30:13 AM
ANN ARBOR, Mich., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that Nick Colangelo, President and CEO of Aastrom, will present at the 3rd Annual Regenerative Medicine Partnering Forum at the 2013 Stem Cell Meeting on the Mesa conference on Monday, October 14 at 10:30 a.m. PDT at the Estancia La Jolla Hotel in San Diego, CA.
Help employers find you! Check out all the jobs and post your resume.
comments powered by